AU3296589A - Recombinant igf binding protein (ibp-1) - Google Patents

Recombinant igf binding protein (ibp-1)

Info

Publication number
AU3296589A
AU3296589A AU32965/89A AU3296589A AU3296589A AU 3296589 A AU3296589 A AU 3296589A AU 32965/89 A AU32965/89 A AU 32965/89A AU 3296589 A AU3296589 A AU 3296589A AU 3296589 A AU3296589 A AU 3296589A
Authority
AU
Australia
Prior art keywords
ibp
binding protein
igf binding
recombinant igf
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32965/89A
Other languages
English (en)
Inventor
Arend Brinkman
Stenwert Leonard Sebastian Drop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Erasmus Universiteit Rotterdam
Original Assignee
ERASMUS, University of
Erasmus Universiteit Rotterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ERASMUS, University of, Erasmus Universiteit Rotterdam filed Critical ERASMUS, University of
Publication of AU3296589A publication Critical patent/AU3296589A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU32965/89A 1988-03-11 1989-03-10 Recombinant igf binding protein (ibp-1) Abandoned AU3296589A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK131988A DK131988A (da) 1988-03-11 1988-03-11 Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
DK1319/88 1988-03-11

Publications (1)

Publication Number Publication Date
AU3296589A true AU3296589A (en) 1989-10-05

Family

ID=8103523

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32965/89A Abandoned AU3296589A (en) 1988-03-11 1989-03-10 Recombinant igf binding protein (ibp-1)

Country Status (5)

Country Link
EP (1) EP0404812A1 (fr)
JP (1) JPH03504494A (fr)
AU (1) AU3296589A (fr)
DK (1) DK131988A (fr)
WO (1) WO1989008667A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
AU1955388A (en) * 1988-04-12 1989-11-03 Synergen, Inc. Method for potentiating and inhibiting insulin-like growth factor activity
CA1341598C (fr) * 1988-07-15 2009-09-29 Central Sydney Area Health Service Sous-unite labile en milieu acide d'un complexe proteique se liant a un factuer de croissance insulinuide
US5324820A (en) * 1988-07-15 1994-06-28 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
US6465423B1 (en) 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
WO1992003152A1 (fr) * 1990-08-28 1992-03-05 Chiron Corporation Nouvelle proteine de liaison de facteur de croissance analogue a l'insuline (igfbp-4)
US5212074A (en) * 1990-08-28 1993-05-18 Chiron Corporation Genetic material encoding new insulin-like growth factor binding protein igfbp-6
EP0546110B1 (fr) * 1990-08-28 2001-11-14 Chiron Corporation Nouvelle proteine de liaison de facteur de croissance analogue a l'insuline igfbp-5
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
US6326154B1 (en) 1990-11-19 2001-12-04 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
CA2100083A1 (fr) 1991-01-08 1992-07-09 Michael C. Kiefer Proteine se liant au facteur de croissance de substances apparentees a l'insuline (igfbp)
US5198340A (en) * 1991-01-17 1993-03-30 Genentech, Inc. Assay for free igf-i, igf-ii, and gh levels in body fluids
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
US6420172B1 (en) 1992-04-20 2002-07-16 Tib Company, Llc Method for inducing tumor immunity
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
EP0668879B1 (fr) 1992-11-04 2003-06-25 Chiron Corporation Proteines tronquees de liaison au facteur de croissance insulinoide a activite mitogene
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
AU6626794A (en) * 1993-04-07 1994-10-24 Amgen Boulder Inc. Methods of using insulin-like growth factor binding proteins
WO1995003817A1 (fr) * 1993-08-03 1995-02-09 Celtrix Pharmaceuticals, Inc. Procede de traitement de dysfonctionnements de la reproduction
EP1217067A2 (fr) 1994-07-12 2002-06-26 Human Genome Sciences, Inc. Facteur de croissance 2 de tissu conjonctif
US7026299B2 (en) 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
EP0800530A4 (fr) * 1994-07-20 1998-12-02 Celtrix Pharma Complexe igf/igfbp destines a favoriser la formation osseuse et a reguler le remodelage osseux
US5994302A (en) * 1994-12-09 1999-11-30 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
US5747280A (en) * 1995-06-05 1998-05-05 Human Genome Sciences, Inc. Human vascular IBP-like growth factor
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
JP3971108B2 (ja) 1999-01-06 2007-09-05 ジェネンテック・インコーポレーテッド インシュリン様成長因子（ｉｇｆ）ｉ突然変異体
IL143834A0 (en) 1999-01-06 2002-04-21 Genentech Inc Insulin-like growth factor (igf) i mutant variants
ES2301547T3 (es) 2000-05-16 2008-07-01 Genentech, Inc. Tratamiento de trastornos del cartilago.
IL157705A0 (en) 2001-03-14 2004-03-28 Genentech Inc Igf antagonist peptides
WO2005049792A2 (fr) 2003-09-12 2005-06-02 Tercica, Inc. Methodes de traitement de la deficience du facteur de croissance de type insuline 1 (igf-1)
AU2004278311A1 (en) 2003-10-03 2005-04-14 Genentech, Inc. IGF binding proteins
BR112020004760A2 (pt) 2017-09-11 2020-09-15 Shire Human Genetic Therapies, Inc métodos e composições para tratamento de doenças pulmonares crônicas
KR20230113287A (ko) 2020-10-19 2023-07-28 오크 힐 바이오 리미티드 신생아에 사용하기에 적합한 조성물
WO2023139115A1 (fr) 2022-01-19 2023-07-27 Oak Hill Bio Limited Compositions et procédés pour réduire l'oxydation d'igf‐1/igfbp
WO2023242439A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Stabilisation vasculaire (nourrissons prématurés)
WO2023242440A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Traitement des poumons chez les nourrissons
WO2023242442A1 (fr) 2022-06-17 2023-12-21 Oak Hill Bio Limited Procédé de maturation/différenciation de neurones et/ou de modulation du nerf vague

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338480A1 (de) * 1983-10-22 1985-05-02 Behringwerke Ag, 3550 Marburg Neues protein pp(pfeil abwaerts)2(pfeil abwaerts)(pfeil abwaerts)0(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung

Also Published As

Publication number Publication date
DK131988A (da) 1989-09-12
DK131988D0 (da) 1988-03-11
JPH03504494A (ja) 1991-10-03
EP0404812A1 (fr) 1991-01-02
WO1989008667A1 (fr) 1989-09-21

Similar Documents

Publication Publication Date Title
AU3296589A (en) Recombinant igf binding protein (ibp-1)
AU5283793A (en) Recombinant specific binding protein
IL90872A0 (en) Retroviral protease binding peptides
AU1628895A (en) Recombinant virus
AU1376688A (en) Recombinant avipoxvirus
AU3342689A (en) Luminescent chimeric proteins
AU7831787A (en) Improved recombinant expression
GB9225453D0 (en) Binding proteins
AU2222888A (en) Recombinant avipoxvirus
AU1072988A (en) Anticoagulant peptides
AU3964489A (en) Retroviral protease binding peptides
AU2414288A (en) Polypeptide compounds
AU590016B2 (en) Peptides
GB8823068D0 (en) Recombinant dna
AU3977589A (en) Novel peptides
AU3108389A (en) Polypeptides
AU575725B2 (en) Improved protein hydrolysate
AU3804589A (en) Novel proteins
AU4538285A (en) Recombinant factor viii-r
AU2117388A (en) Recombinant htlv-iii proteins and uses thereof
AU3804689A (en) Modified proteins
AU5559786A (en) Recombinant human rennin
AU3231189A (en) Recombinant endonexin ii
AU1294888A (en) Recombinant alveolar surfactant protein
PT86162A (en) Recombinant protein expression